Annual accounts receivable:
$92.19M-$5.59M(-5.72%)Summary
- As of today (August 20, 2025), IONS annual accounts receivable is $92.19 million, with the most recent change of -$5.59 million (-5.72%) on December 31, 2024.
- During the last 3 years, IONS annual accounts receivable has risen by +$30.29 million (+48.94%).
- IONS annual accounts receivable is now -14.67% below its all-time high of $108.04 million, reached on December 31, 2016.
Performance
IONS Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$52.58M+$12.87M(+32.42%)Summary
- As of today (August 20, 2025), IONS quarterly accounts receivable is $52.58 million, with the most recent change of +$12.87 million (+32.42%) on June 30, 2025.
- Over the past year, IONS quarterly accounts receivable has increased by +$25.32 million (+92.89%).
- IONS quarterly accounts receivable is now -63.07% below its all-time high of $142.36 million, reached on September 30, 2023.
Performance
IONS Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
IONS Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.7% | +92.9% |
| 3 y3 years | +48.9% | +678.9% |
| 5 y5 years | +46.3% | +88.9% |
IONS Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.7% | +261.0% | -63.1% | +923.0% |
| 5 y | 5-year | -5.7% | +261.0% | -63.1% | +923.0% |
| alltime | all time | -14.7% | >+9999.0% | -63.1% | +9972.8% |
IONS Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $52.58M(+32.4%) |
| Mar 2025 | - | $39.71M(-56.9%) |
| Dec 2024 | $92.19M(-5.7%) | $92.19M(+414.2%) |
| Sep 2024 | - | $17.93M(-34.2%) |
| Jun 2024 | - | $27.26M(+430.3%) |
| Mar 2024 | - | $5.14M(-94.7%) |
| Dec 2023 | $97.78M(+282.9%) | $97.78M(-31.3%) |
| Sep 2023 | - | $142.36M(+409.2%) |
| Jun 2023 | - | $27.96M(+100.9%) |
| Mar 2023 | - | $13.91M(-45.5%) |
| Dec 2022 | $25.54M(-58.7%) | $25.54M(+284.3%) |
| Sep 2022 | - | $6.64M(-1.6%) |
| Jun 2022 | - | $6.75M(-74.2%) |
| Mar 2022 | - | $26.12M(-57.8%) |
| Dec 2021 | $61.90M(-18.8%) | $61.90M(+582.6%) |
| Sep 2021 | - | $9.07M(-62.2%) |
| Jun 2021 | - | $24.00M(+2.6%) |
| Mar 2021 | - | $23.40M(-69.3%) |
| Dec 2020 | $76.20M(+20.9%) | $76.20M(+95.5%) |
| Sep 2020 | - | $38.98M(+40.0%) |
| Jun 2020 | - | $27.83M(-2.7%) |
| Mar 2020 | - | $28.61M(-54.6%) |
| Dec 2019 | $63.03M(+394.0%) | $63.03M(+28.4%) |
| Sep 2019 | - | $49.08M(+55.2%) |
| Jun 2019 | - | $31.61M(+202.5%) |
| Mar 2019 | - | $10.45M(-18.1%) |
| Dec 2018 | $12.76M(-79.7%) | $12.76M(-13.4%) |
| Sep 2018 | - | $14.73M(-12.1%) |
| Jun 2018 | - | $16.76M(-54.5%) |
| Mar 2018 | - | $36.86M(-41.5%) |
| Dec 2017 | $62.95M(-41.7%) | $62.95M(+46.7%) |
| Sep 2017 | - | $42.92M(-15.2%) |
| Jun 2017 | - | $50.62M(-27.0%) |
| Mar 2017 | - | $69.36M(-35.8%) |
| Dec 2016 | $108.04M(+851.4%) | $108.04M(+1164.5%) |
| Sep 2016 | - | $8.54M(+1045.3%) |
| Jun 2016 | - | $746.00K(-95.5%) |
| Mar 2016 | - | $16.48M(+45.1%) |
| Dec 2015 | $11.36M(+191.0%) | $11.36M(+521.9%) |
| Sep 2015 | - | $1.83M(-44.1%) |
| Jun 2015 | - | $3.26M(-87.9%) |
| Mar 2015 | - | $26.93M(+590.1%) |
| Dec 2014 | $3.90M(-64.8%) | $3.90M(-85.2%) |
| Sep 2014 | - | $26.31M(-37.3%) |
| Jun 2014 | - | $41.94M(+327.0%) |
| Mar 2014 | - | $9.82M(-11.5%) |
| Dec 2013 | $11.10M(+2026.8%) | $11.10M(-12.2%) |
| Sep 2013 | - | $12.64M(+524.8%) |
| Jun 2013 | - | $2.02M(+72.7%) |
| Mar 2013 | - | $1.17M(+124.5%) |
| Dec 2012 | $522.00K | $522.00K(-85.0%) |
| Sep 2012 | - | $3.48M(+123.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $1.56M(+13.0%) |
| Mar 2012 | - | $1.38M(-80.1%) |
| Dec 2011 | $6.92M(+457.2%) | $6.92M(+272.5%) |
| Sep 2011 | - | $1.86M(-67.3%) |
| Jun 2011 | - | $5.67M(+860.1%) |
| Mar 2011 | - | $591.00K(-52.4%) |
| Dec 2010 | $1.24M(-88.6%) | $1.24M(-7.4%) |
| Sep 2010 | - | $1.34M(-73.4%) |
| Jun 2010 | - | $5.04M(+164.7%) |
| Mar 2010 | - | $1.90M(-82.5%) |
| Dec 2009 | $10.90M(+164.5%) | $10.90M(+1759.9%) |
| Sep 2009 | - | $586.00K(-25.2%) |
| Jun 2009 | - | $783.00K(-66.7%) |
| Mar 2009 | - | $2.35M(-43.0%) |
| Dec 2008 | $4.12M(-33.3%) | $4.12M(-17.9%) |
| Sep 2008 | - | $5.02M(-21.5%) |
| Jun 2008 | - | $6.40M(+46.8%) |
| Mar 2008 | - | $4.36M(-29.4%) |
| Dec 2007 | $6.18M(+157.9%) | $6.18M(-33.1%) |
| Sep 2007 | - | $9.24M(+302.3%) |
| Jun 2007 | - | $2.30M(+11.6%) |
| Mar 2007 | - | $2.06M(-14.1%) |
| Dec 2006 | $2.40M(-38.9%) | $2.40M(-19.1%) |
| Sep 2006 | - | $2.96M(-15.5%) |
| Mar 2006 | - | $3.50M(-10.6%) |
| Dec 2005 | $3.92M(-61.0%) | $3.92M(-12.1%) |
| Jun 2005 | - | $4.46M(+53.1%) |
| Mar 2005 | - | $2.91M(-71.0%) |
| Dec 2004 | $10.05M(+278.2%) | $10.05M(+83.9%) |
| Sep 2004 | - | $5.46M(-43.0%) |
| Jun 2004 | - | $9.59M(+66.1%) |
| Mar 2004 | - | $5.77M(+117.3%) |
| Dec 2003 | $2.66M(-82.2%) | $2.66M(-3.3%) |
| Sep 2003 | - | $2.75M(+0.9%) |
| Jun 2003 | - | $2.73M(-45.3%) |
| Mar 2003 | - | $4.98M(-66.6%) |
| Dec 2002 | $14.91M(>+9900.0%) | $14.91M(+263.8%) |
| Sep 2001 | - | $4.10M(+95.3%) |
| Jun 2001 | - | $2.10M(-56.3%) |
| Mar 2001 | - | $4.80M(+43.5%) |
| Dec 2000 | - | $3.35M(-51.8%) |
| Sep 2000 | - | $6.94M(+49.5%) |
| Jun 2000 | - | $4.64M(-14.0%) |
| Dec 1999 | - | $5.40M(+54.3%) |
| Dec 1998 | - | $3.50M |
| Dec 1997 | $0.00(0.0%) | - |
| Dec 1996 | $0.00(0.0%) | - |
| Dec 1995 | $0.00(0.0%) | - |
| Dec 1994 | $0.00(0.0%) | - |
| Dec 1993 | $0.00(0.0%) | - |
| Dec 1992 | $0.00(0.0%) | - |
| Dec 1991 | $0.00 | - |
FAQ
- What is Ionis Pharmaceuticals, Inc. annual accounts receivable?
- What is the all time high annual accounts receivable for Ionis Pharmaceuticals, Inc.?
- What is Ionis Pharmaceuticals, Inc. annual accounts receivable year-on-year change?
- What is Ionis Pharmaceuticals, Inc. quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Ionis Pharmaceuticals, Inc.?
- What is Ionis Pharmaceuticals, Inc. quarterly accounts receivable year-on-year change?
What is Ionis Pharmaceuticals, Inc. annual accounts receivable?
The current annual accounts receivable of IONS is $92.19M
What is the all time high annual accounts receivable for Ionis Pharmaceuticals, Inc.?
Ionis Pharmaceuticals, Inc. all-time high annual accounts receivable is $108.04M
What is Ionis Pharmaceuticals, Inc. annual accounts receivable year-on-year change?
Over the past year, IONS annual accounts receivable has changed by -$5.59M (-5.72%)
What is Ionis Pharmaceuticals, Inc. quarterly accounts receivable?
The current quarterly accounts receivable of IONS is $52.58M
What is the all time high quarterly accounts receivable for Ionis Pharmaceuticals, Inc.?
Ionis Pharmaceuticals, Inc. all-time high quarterly accounts receivable is $142.36M
What is Ionis Pharmaceuticals, Inc. quarterly accounts receivable year-on-year change?
Over the past year, IONS quarterly accounts receivable has changed by +$25.32M (+92.89%)